Foghorn Therapeutics Inc.
Price Action
Technical Summary
CONSOLIDATINGFoghorn Therapeutics Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 62), indicating performance broadly in line with the market. Earnings growth of 3% provides fundamental context to the price action. However, with RSI at 75, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.27 | +18.17% | ABOVE |
| 50 SMA | $4.32 | +17.00% | ABOVE |
| 100 SMA | $4.77 | +5.95% | ABOVE |
| 150 SMA | $4.94 | +2.26% | ABOVE |
| 200 SMA | $4.82 | +4.68% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is FHTX in an uptrend right now?
FHTX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is FHTX overbought or oversold?
FHTX's RSI (14) is 75. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is FHTX outperforming the market?
FHTX has a Relative Strength (RS) Rating of 62 out of 99. FHTX is performing about average compared to the market.
Where is FHTX in its 52-week range?
FHTX is trading at $5.05, which is 73% of its 52-week high ($6.95) and 48% above its 52-week low ($3.27).
How volatile is FHTX?
FHTX has a Beta of 2.17 and 52-week volatility of 75%. It's more volatile than the S&P 500 - expect bigger swings.